To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $18,909,555 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 120 grants at over 100 hospitals in 17 countries.
Institute of Cancer Research - $121,863
Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.
Bambino Gesu Children's Hospital - $49,803
Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.
Telethon Kids Institute - $49,512
Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.
Funding of Pediatric Brain Tumor Consortium Foundation - $25,000
Sydney Children’s Hospital - $175,089
Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital - $540,742
Expansion of the International DIPG Registry.
Bambino Gesú Children's Hospital - $99,382
Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.
Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000
Credentialing an Improved DIPG Mouse Model.
The Institute of Cancer Research - $100,000
Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children
The Institute of Cancer Research - $106,647
A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.
Johns Hopkins Children's Center - $50,000
Using Zebrafish to Accelerate DIPG Drug Development.
Funding of Pediatric Brain Tumor Consortium Foundation - $16,800
The Campbell Family Institute for Cancer Research - $100,000
Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets